Vaccibody – a novel generation of vaccines

Vaccibody is a vaccine company dedicated to the development of novel vaccines that overcome shortcomings of current vaccine technologies. The Company’s proprietary vaccine platform increases the antibody and T-cell responses leading to remarkably effective vaccines. Vaccibody is focusing on cancer vaccines and is partnering the technology within infection and veterinary use.

 

International Vaccibody presscoverage

In  Science Daily and Alpha Gallieo Foundation.

 
Vaccibody in the press

Aftenposten interviews Bjarne Bogen on the Vaccibody technology.  Bogen, together with professor Inger Sandlie and Vaccibody CSO, Agnete Fredriksen are the three inventors of the Vaccibody technology. In Norwegian only.  Read it here.